SPI
18.551,09
PKT
+155,85
PKT
+0,85
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 20.12.11 | Peach Property Group buy | SRC Research GmbH | |
| 20.12.11 | Implenia buy | Vontobel Research | |
| 20.12.11 | Swatch (I) buy | Vontobel Research | |
| 20.12.11 | SGS SA buy | Vontobel Research | |
| 19.12.11 | Holcim hold | Deutsche Bank AG | |
| 19.12.11 | Holcim hold | Deutsche Bank AG | |
| 19.12.11 | Zurich Insurance buy | Nomura | |
| 16.12.11 | Novartis outperform | Credit Suisse Group | |
| 16.12.11 | Swiss Re overweight | J.P. Morgan Cazenove | |
| 16.12.11 | Roche outperform | Credit Suisse Group | |
| 16.12.11 | Holcim neutral | UBS AG | |
| 16.12.11 | u-blox hold | Vontobel Research | |
| 15.12.11 | UBS neutral | WestLB AG | |
| 15.12.11 | Swatch (I) neutral | J.P. Morgan Cazenove | |
| 15.12.11 | Roche buy | Deutsche Bank AG | |
| 15.12.11 | Swisscom buy | Société Générale Group S.A. (SG) | |
| 15.12.11 | u-blox hold | Vontobel Research | |
| 15.12.11 | Swiss Life buy | Vontobel Research | |
| 15.12.11 | Swisscom hold | Vontobel Research | |
| 15.12.11 | Novartis hold | Vontobel Research | |
| 14.12.11 | Roche overweight | J.P. Morgan Cazenove | |
| 14.12.11 | Novartis overweight | J.P. Morgan Cazenove | |
| 14.12.11 | Swisscom hold | Vontobel Research | |
| 14.12.11 | Sika buy | Vontobel Research | |
| 14.12.11 | Rieter hold | Vontobel Research | |
| 13.12.11 | Holcim hold | Deutsche Bank AG | |
| 13.12.11 | Holcim buy | Deutsche Bank AG | |
| 13.12.11 | UBS halten | Norddeutsche Landesbank (Nord/LB) | |
| 13.12.11 | Swiss Re underperform | Banc of America Securities-Merrill Lynch | |
| 13.12.11 | Holcim neutral | UBS AG | |
| 13.12.11 | UBS halten | Norddeutsche Landesbank (Nord/LB) | |
| 13.12.11 | Novartis buy | WestLB AG | |
| 13.12.11 | Givaudan underperform | Cheuvreux SA | |
| 13.12.11 | Roche outperform | Credit Suisse Group | |
| 13.12.11 | Holcim hold | Vontobel Research | |
| 13.12.11 | Orell Fuessli hold | Vontobel Research | |
| 13.12.11 | Cicor Technologies buy | Vontobel Research | |
| 13.12.11 | Novartis hold | Vontobel Research | |
| 13.12.11 | Novartis outperform | Credit Suisse Group | |
| 12.12.11 | ABB (Asea Brown Boveri) overweight | J.P. Morgan Cazenove |